Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenxin Luo

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Cell Reports. Medicine|March 19, 2026
A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancerWenjing Ning, Han Liu, Hongye Zeng, et al.
Nature Communications|November 12, 2021
Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencingZhoufeng Wang, Zhe Li, Kun Zhou, et al.
Cell Reports. Medicine|June 10, 2023
Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokersWenxin Luo, Zhen Zeng, Yang Jin, et al.
Theranostics|January 22, 2019
An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potencyChenguang Shen, Minwei Zhang, Yuanzhi Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2024
A Dual-domain Engineered Antibody for Efficient HBV Suppression and Immune Responses RestorationYichao Jiang, Xiaoqing Chen, Xinya Ye, et al.
Antiviral Research|November 13, 2018
A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potentialBing Zhou, Longfa Xu, Rui Zhu, et al.
Cancer Research|June 19, 2019
The Open Chromatin Landscape of Non-Small Cell Lung CarcinomaZhoufeng Wang, Kailing Tu, Lin Xia, et al.
Gut|November 6, 2025
Engineered virus-hunter vaccine overcomes HBV immune toleranceXiaoqing Chen, Xue Liu, Tao Xu, et al.
Journal for Immunotherapy of Cancer|August 11, 2020
Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cellsHeyu Chen, Yuanzhi Chen, Mi Deng, et al.
Frontiers in Immunology|July 25, 2022
Single-Cell Transcriptomics of Immune Cells Reveal Diversity and Exhaustion Signatures in Non-Small-Cell Lung CancerYing Zhao, Qilin Zhang, Kailin Tu, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Cell Reports. Medicine|March 19, 2026
A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancerWenjing Ning, Han Liu, Hongye Zeng, et al.
Nature Communications|November 12, 2021
Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencingZhoufeng Wang, Zhe Li, Kun Zhou, et al.
Cell Reports. Medicine|June 10, 2023
Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokersWenxin Luo, Zhen Zeng, Yang Jin, et al.
Theranostics|January 22, 2019
An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potencyChenguang Shen, Minwei Zhang, Yuanzhi Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2024
A Dual-domain Engineered Antibody for Efficient HBV Suppression and Immune Responses RestorationYichao Jiang, Xiaoqing Chen, Xinya Ye, et al.
Antiviral Research|November 13, 2018
A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potentialBing Zhou, Longfa Xu, Rui Zhu, et al.
Cancer Research|June 19, 2019
The Open Chromatin Landscape of Non-Small Cell Lung CarcinomaZhoufeng Wang, Kailing Tu, Lin Xia, et al.
Gut|November 6, 2025
Engineered virus-hunter vaccine overcomes HBV immune toleranceXiaoqing Chen, Xue Liu, Tao Xu, et al.
Journal for Immunotherapy of Cancer|August 11, 2020
Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cellsHeyu Chen, Yuanzhi Chen, Mi Deng, et al.
Frontiers in Immunology|July 25, 2022
Single-Cell Transcriptomics of Immune Cells Reveal Diversity and Exhaustion Signatures in Non-Small-Cell Lung CancerYing Zhao, Qilin Zhang, Kailin Tu, et al.
Pageof 12